Christopher Rovaldi - Net Worth and Insider Trading
Christopher Rovaldi Net Worth
The estimated net worth of Christopher Rovaldi is at least $5 Million dollars as of 2024-12-27. Christopher Rovaldi is the SVP, Program Mgmt and Ops of Acceleron Pharma Inc and owns about 25,858 shares of Acceleron Pharma Inc (XLRN) stock worth over $5 Million. Christopher Rovaldi is also the COO of Keros Therapeutics Inc and owns about 0 shares of Keros Therapeutics Inc (KROS) stock worth over $0. Details can be seen in Christopher Rovaldi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Rovaldi has not made any transactions after 2022-04-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Rovaldi
Christopher Rovaldi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Rovaldi owns 2 companies in total, including Acceleron Pharma Inc (XLRN) , and Keros Therapeutics Inc (KROS) .
Click here to see the complete history of Christopher Rovaldi’s form 4 insider trades.
Insider Ownership Summary of Christopher Rovaldi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2018-04-03 | SVP & Program Mgmt and Ops |
| KROS | Keros Therapeutics Inc | 2022-04-06 | Chief Operating Officer |
Christopher Rovaldi Latest Holdings Summary
Christopher Rovaldi currently owns a total of 2 stocks. Among these stocks, Christopher Rovaldi owns 25,858 shares of Acceleron Pharma Inc (XLRN) as of April 3, 2018, with a value of $5 Million and a weighting of 100%. Christopher Rovaldi also owns 0 shares of Keros Therapeutics Inc (KROS) as of April 6, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Christopher Rovaldi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XLRN | Acceleron Pharma Inc | 2018-04-03 | 25,858 | 178.75 | 4,622,118 |
| KROS | Keros Therapeutics Inc | 2022-04-06 | 0 | 16.81 | 0 |
Holding Weightings of Christopher Rovaldi
Christopher Rovaldi Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Rovaldi has made a total of 0 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years. The most-recent trade in Acceleron Pharma Inc is the sale of 3,500 shares on April 3, 2018, which brought Christopher Rovaldi around $134,400.
According to the SEC Form 4 filings, Christopher Rovaldi has made a total of 2 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 1,728 shares on April 6, 2022, which brought Christopher Rovaldi around $112,320.
Insider Trading History of Christopher Rovaldi
- 1
Christopher Rovaldi Trading Performance
Christopher Rovaldi Ownership Network
Christopher Rovaldi Owned Company Details
What does Acceleron Pharma Inc do?
Who are the key executives at Acceleron Pharma Inc?
Christopher Rovaldi is the SVP & Program Mgmt and Ops of Acceleron Pharma Inc. Other key executives at Acceleron Pharma Inc include EVP & Chief Commercial Officer Sujay Kango , SVP & CFO and Treasurer Kevin F Mclaughlin , and SVP & General Counsel and Sec. Adam M Veness .
Acceleron Pharma Inc (XLRN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acceleron Pharma Inc (XLRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acceleron Pharma Inc (XLRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acceleron Pharma Inc (XLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acceleron Pharma Inc Insider Transactions
Christopher Rovaldi Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Rovaldi. You might contact Christopher Rovaldi via mailing address: C/o Acceleron Pharma Inc., 128 Sidney St., Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
